Stock FPMI FLUOROPHARMA MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News FluoroPharma Medical, Inc.

Equities

FPMI

US3438701019

Market Closed - OTC Markets
Other stock markets
 11:35:55 2024-02-26 am EST 		5-day change 1st Jan Change
0.0001 USD -50.00% Intraday chart for FluoroPharma Medical, Inc. -.--% -.--%
2022 FluoroPharma Medical, Inc. Announces Executive Changes CI
2022 FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FluoroPharma Medical, Inc. Announces Executive Changes
CI
FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO
CI
FLUOROPHARMA MEDICAL, INC. : Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
FluoroPharma Medical, Inc. Restructures CardioPET License With Massachusetts General Hospital
CI
FluoroPharma Medical, Inc. cancelled the acquisition of Ground Fluor Pharmaceuticals, Inc.
CI
FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
FluoroPharma Medical, Inc. Announces Resignation of Lawrence Atinsky as Director and Member of Audit Committee and Compensation Committee of the Board of Directors
CI
FluoroPharma Medical, Inc. Borrows $50,000 in the Form of Promissory Note; Announces Board Resignations, Effective January 1, 2017
CI
FluoroPharma Medical, Inc. announced that it has received $0.57 million in funding
CI
FluoroPharma Medical Inc. and Royal Philips Collaborate on Image Management for CardioPET Phase II Clinical Trial
CI
FluoroPharma Medical, Inc. (OTCPK: FPMI) entered into a nonbinding letter of intent to acquire Ground Fluor Pharmaceuticals, Inc.
CI
FluoroPharma Medical, Inc. Enters into Development and Commercialization Agreement with Sinotau USA Inc. for China and Canada
CI
Fluoropharma Medical Inc. Accepts First Comparative Data from it's Phase II Trial of CardioPET in Subjects with High Likelihood of Coronary Artery Disease
CI
FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
FluoroPharma Medical, Inc. announced that it expects to receive $1 million in funding
CI
FluoroPharma Medical, Inc. Announces Resignation of Andrew H. Sassine as Member of the Board of Directors
CI
FluoroPharma Medical, Inc. Announces Management Appointments
CI
FluoroPharma Medical, Inc. Announces Board Changes
CI
FluoroPharma Medical Inc Appoints Dr. Thomas H. Tulip as President
CI
FluoroPharma Medical, Inc. announced that it has received $2.78 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FPMI Stock
  4. News FluoroPharma Medical, Inc.